Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Michael Horton

2106 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • FDA
  • News

Y-mAbs Announces Complete Response Letter For Omburtamab Biologics License Application

By Michael Horton
December 1, 6:36 PM
Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic

YMAB

Read More
1 minute read
  • Dividends
  • News

Raymond James Financial Raises Quarterly Dividend From $0.34/Share To $0.42/Share; Co. Authorizes $1.5B Share Repurchase To Replace Previously Authorized $1B Program

By Michael Horton
December 1, 6:30 PM
On December 1, 2022, the Raymond James Financial, Inc. (NYSE:RJF) Board of Directors declared a quarterly cash dividend on shares of its common stock of $0.42 per share, payable January 17, 2023 to shareholders

RJF

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News

Rigel Announces U.S. FDA Approval Of REZLIDHIA (olutasidenib) For Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia With a Susceptible IDH1 Mutation

By Michael Horton
December 1, 6:05 PM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that the U.S. Food and Drug Administration (FDA) has approved REZLIDHIA™ (olutasidenib) capsules for the treatment of adult patients with relapsed or

RIGL

Read More
1 minute read
  • News

Royalty Pharma Says Concluded Non-Cash Impairment Charge Related To Financial Royalty Asset Assocaited With Gantenerumab Is Required Under GAAP In 3 Months Ending Dec. 31, 2022; Says Expects Non-Cash Impairment Charge Will Be $273.6M

By Michael Horton
December 1, 6:02 PM
-SEC Filing

RPRX

Read More
1 minute read
  • News

One Equity Partners Open Water I Obtains Stockholder Approval To Terminate Before Year-End

By Michael Horton
December 1, 5:57 PM
One Equity Partners Open Water I Corp. (NASDAQ:OEPW, OEPW and OEPWW)))) (the "Company") held a special meeting of stockholders on December 1, 2022, at 10:00 a.m., Eastern Time, at the offices of Kirkland &

OEPW

Read More
1 minute read
  • News
  • Offerings

Paycor Announces Offering Off 5M Shares Of Common Stock By Selling Stockholders

By Michael Horton
December 1, 5:54 PM
Paycor HCM, Inc. (NASDAQ:PYCR) ("Paycor"), a leading provider of human capital management (HCM) software, today announced the commencement of an underwritten public offering of 5,000,000 shares of common stock

PYCR

Read More
1 minute read
  • News

‘Tesla Reportedly Offering $3750 Discount For December Model 3/Model Y Deliveries’ -CleanTechnica

By Michael Horton
December 1, 5:47 PM
https://cleantechnica.com/2022/12/01/tesla-reportedly-offering-3750-discount-for-december-model-3-model-y-deliveries/

TSLA

Read More
1 minute read
  • Management
  • News

Molecular Therapeutics Says On Nov. 28, 2022 Interim CFO, Treasurer, SVP Sean McLennan Informed Co. Of Intent To Resign From Positions; Co. Appointed Jason Kim As Interim CFO

By Michael Horton
December 1, 5:44 PM
-SEC Filing

MTEM

Read More
1 minute read
  • Dividends
  • News

Eastman Chemical Raises Quarterly Dividend From $0.76/Share To $0.79/Share

By Michael Horton
December 1, 5:41 PM
The Board of Directors of Eastman Chemical Company (NYSE:EMN) has declared a quarterly cash dividend of $0.79 per share on the company's common stock, a 4 percent increase from $0.76 per

EMN

Read More
1 minute read
  • News

Accuray Says Informed Employees Of Cost Saving Initiative Designed To Reduce Operating Costs Through Elimination Of About 4.5% Of Global Workforce, Says Co. Expects To Substantially Complete Initiative In Q2’23

By Michael Horton
December 1, 5:27 PM
-SEC Filing

ARAY

Posts pagination

Previous 1 … 90 91 92 … 211 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service